Načítá se...

Preventive effect of zoledronic acid on aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole

BACKGROUND: This study aims to compare the efficacy and safety between zoledronic acid combined with calcium and calcium alone to prevent aromatase inhibitor-associated bone loss for postmenopausal breast cancer patients receiving adjuvant letrozole. METHODS: One hundred twenty patients were randoml...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Sun, Shengliang, Wang, Fuchao, Dou, Honglei, Zhang, Longqiang, Li, Jiwen
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5063560/
https://ncbi.nlm.nih.gov/pubmed/27785049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S115058
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!